000858406 001__ 858406
000858406 005__ 20230411070828.0
000858406 020__ $$a978-1-78801-074-0
000858406 037__ $$aFZJ-2018-07292
000858406 041__ $$aEnglish
000858406 1001_ $$0P:(DE-Juel1)131818$$aErmert, Johannes$$b0$$eCorresponding author$$ufzj
000858406 245__ $$aChapter 20, Part E: Radiotracers for PET and  MR-PET Imaging
000858406 260__ $$aCambridge$$bRoyal Society of Chemistry$$c2018
000858406 29510 $$a-Hybrid MR-PET Imaging: Systems, Methods and Applications / Shah, N Jon (Editor); Cambridge : Royal Society of Chemistry, 2018,  ; ISBN:  ; doi:10.1039/9781788013062
000858406 300__ $$a381-399
000858406 3367_ $$2ORCID$$aBOOK_CHAPTER
000858406 3367_ $$07$$2EndNote$$aBook Section
000858406 3367_ $$2DRIVER$$abookPart
000858406 3367_ $$2BibTeX$$aINBOOK
000858406 3367_ $$2DataCite$$aOutput Types/Book chapter
000858406 3367_ $$0PUB:(DE-HGF)7$$2PUB:(DE-HGF)$$aContribution to a book$$bcontb$$mcontb$$s1557840964_23396
000858406 4900_ $$aNew Developments in NMR
000858406 520__ $$aPositron emission tomography (PET) combined with magnetic resonance (MR) is a rapidly expanding imaging modality. For this application, the availability of radiotracers labelled with positron emitters is a basic requirement. These short-lived neutron deficient positron emitters are produced at a cyclotron. In a cyclotron, charged particles are accelerated up to energies enabling to overcome Coulomb repulsion and induce nuclear reactions. The beam is extracted to target systems containing stable isotopes. Due to the bombardment, these stable isotopes are converted via nuclear reactions into radionuclides. The positron emitters are subsequently used for radiolabelling molecules to obtain radiotracers for various applications. Usually radiosyntheses are carried out in automated synthesis modules. The relatively short physical half-life of the positron emitters in use requires fast and efficient radiolabelling strategies that have been optimised for the most common radiopharmaceuticals in order to facilitate robust tracer production in sufficient activity amounts. Beside the PET alone approach, emerging methods deal with simultaneous PET-MR imaging to combine the high sensitivity of PET with the high resolution of MR. One possibility to exploit the synergy of both techniques is the combination of clinically established paramagnetic contrast agents and radiopharmaceuticals. This method was studied in several preclinical and clinical studies. A much more elegant possibility is the introduction of both modalities in one single, bimodal contrast and positron-emitting probe. Thus far, this technique was only tested in preclinical set-ups.
000858406 536__ $$0G:(DE-HGF)POF3-573$$a573 - Neuroimaging (POF3-573)$$cPOF3-573$$fPOF III$$x0
000858406 588__ $$aDataset connected to CrossRef Book Series
000858406 7001_ $$0P:(DE-Juel1)166419$$aNeumaier, Bernd$$b1$$ufzj
000858406 8564_ $$uhttps://juser.fz-juelich.de/record/858406/files/9781788013062-00379%281%29.pdf$$yRestricted
000858406 8564_ $$uhttps://juser.fz-juelich.de/record/858406/files/9781788013062-00379%281%29.pdf?subformat=pdfa$$xpdfa$$yRestricted
000858406 909CO $$ooai:juser.fz-juelich.de:858406$$pVDB
000858406 9141_ $$y2018
000858406 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131818$$aForschungszentrum Jülich$$b0$$kFZJ
000858406 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)166419$$aForschungszentrum Jülich$$b1$$kFZJ
000858406 9131_ $$0G:(DE-HGF)POF3-573$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$vNeuroimaging$$x0
000858406 920__ $$lyes
000858406 9201_ $$0I:(DE-Juel1)INM-5-20090406$$kINM-5$$lNuklearchemie$$x0
000858406 9201_ $$0I:(DE-Juel1)INM-4-20090406$$kINM-4$$lPhysik der Medizinischen Bildgebung$$x1
000858406 9201_ $$0I:(DE-Juel1)INM-11-20170113$$kINM-11$$lJara-Institut Quantum Information$$x2
000858406 9201_ $$0I:(DE-82)080010_20140620$$kJARA-BRAIN$$lJARA-BRAIN$$x3
000858406 980__ $$acontb
000858406 980__ $$aVDB
000858406 980__ $$aI:(DE-Juel1)INM-5-20090406
000858406 980__ $$aI:(DE-Juel1)INM-4-20090406
000858406 980__ $$aI:(DE-Juel1)INM-11-20170113
000858406 980__ $$aI:(DE-82)080010_20140620
000858406 980__ $$aUNRESTRICTED